发明名称 RACEMIZATION AND ENANTIOMER SEPARATION OF CLOPIDOGREL
摘要 <p>Processes for separation of enantiomers of clopidogrel, and converting one enantiomer of clopidogrel to another anantiomer of clopidogrel are provided. The enantiomers are separated by crystallizing the (S) enantiomer as camphor sulfonate salt from a hydrocarbon, or a mixture of a hydrocarbon and a co-solvent, preferably DMF:toluene. The (R) enantiomer is then racemized and recycled by reaction with a catalytic amount of a base, preferably with t-butoxide.</p>
申请公布号 WO2004013147(A1) 申请公布日期 2004.02.12
申请号 WO2002US37680 申请日期 2002.11.22
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD.;TEVA PHARMACEUTICALS USA, INC.;VALERIANO, MERLI;DAVERIO, PAOLA;BIANCHI, STEFANO 发明人 VALERIANO, MERLI;DAVERIO, PAOLA;BIANCHI, STEFANO
分类号 A61K31/4743;C07D513/04;(IPC1-7):C07D495/04;A61K31/436 主分类号 A61K31/4743
代理机构 代理人
主权项
地址